|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Pluri Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
ASLAN Pharmaceuticals Ltd. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Plus Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
XORTX Therapeutics Inc |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Nurix Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Psyence Group Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Lexicon Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Apellis Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
ProMIS Neurosciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Ventyx Biosciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
FibroGen, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
ADMA Biologics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Conduit Pharmaceuticals Limited |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Microbix Biosystems Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Eyenovia, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Regeneron Pharmaceuticals Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Travere Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 11 Mar 2024
|
Related companies:
Lexicon Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 11 Mar 2024
|
|